Vira Shield 6+VL5 HB Somnus

Manufacturer: Novartis (Farm Animal)

Bovine Rhinotracheitis-virus Diarrhea-parainfluenza 3-respiratory Syncytial Virus Vaccine

Killed Virus

Campylobacter Fetus-haemophilus Somnus-leptospira Canicola-grippotyphosa-hardjo-icterohaemorrhagiae-pomona Bacterin

For Use In Animals Only

Vira Shield 6+VL5 HB Somnus Indications

For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI₃), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Haemophilus somnus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.

Adjuvant

Xtend^® SP.

Directions

Shake well before using. Administer 5 mL intramuscularly in the neck 2-4 weeks prior to breeding. Revaccinate with Vira Shield^® 6 + L5^HB Somnus in 4-5 weeks. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3-6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2007 Novartis; Registered trademarks of Novartis AG

10 Doses	50 mL	381-04
50 Doses	250 mL	382-04

Nac No.

11141062